Global Alpha Synuclein Market Growth 2025-2031

October 2025 | 111 pages | ID: G015FBACB5BEEN
LP Information

Abstracts

The global Alpha Synuclein market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Alpha Synuclein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Alpha Synuclein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Alpha Synuclein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Alpha Synuclein players cover AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Alpha Synuclein Industry Forecast? looks at past sales and reviews total world Alpha Synuclein sales in 2024, providing a comprehensive analysis by region and market sector of projected Alpha Synuclein sales for 2025 through 2031. With Alpha Synuclein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alpha Synuclein industry.

This Insight Report provides a comprehensive analysis of the global Alpha Synuclein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alpha Synuclein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Alpha Synuclein market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alpha Synuclein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alpha Synuclein.

This report presents a comprehensive overview, market shares, and growth opportunities of Alpha Synuclein market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• AV-1950R
• AV-1947D
• BAN-0805
• BIIB-054
• DPC-003
• Others

Segmentation by Application:

• Multiple System Atrophy
• Neurodegenerateive Disease
• Lewy Body Dementia
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• AC Immune SA
• AFFiRiS AG
• BioArctic AB
• Biogen Inc
• Evotec AG
• Genmab A/S
• H. Lundbeck A/S
• ICB International Inc
• MedImmune LLC
• Neuropore Therapies Inc
• nLife Therapeutics SL
• Prothena Corp Plc
• QR Pharma Inc
• reMYND NV

Key Questions Addressed in this Report

What is the 10-year outlook for the global Alpha Synuclein market?
What factors are driving Alpha Synuclein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alpha Synuclein market opportunities vary by end market size?
How does Alpha Synuclein break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Alpha Synuclein Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Alpha Synuclein by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Alpha Synuclein by Country/Region, 2020, 2024 & 2031
2.2 Alpha Synuclein Segment by Type
  2.2.1 AV-1950R
  2.2.2 AV-1947D
  2.2.3 BAN-0805
  2.2.4 BIIB-054
  2.2.5 DPC-003
  2.2.6 Others
2.3 Alpha Synuclein Sales by Type
  2.3.1 Global Alpha Synuclein Sales Market Share by Type (2020-2025)
  2.3.2 Global Alpha Synuclein Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Alpha Synuclein Sale Price by Type (2020-2025)
2.4 Alpha Synuclein Segment by Application
  2.4.1 Multiple System Atrophy
  2.4.2 Neurodegenerateive Disease
  2.4.3 Lewy Body Dementia
  2.4.4 Others
2.5 Alpha Synuclein Sales by Application
  2.5.1 Global Alpha Synuclein Sale Market Share by Application (2020-2025)
  2.5.2 Global Alpha Synuclein Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Alpha Synuclein Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Alpha Synuclein Breakdown Data by Company
  3.1.1 Global Alpha Synuclein Annual Sales by Company (2020-2025)
  3.1.2 Global Alpha Synuclein Sales Market Share by Company (2020-2025)
3.2 Global Alpha Synuclein Annual Revenue by Company (2020-2025)
  3.2.1 Global Alpha Synuclein Revenue by Company (2020-2025)
  3.2.2 Global Alpha Synuclein Revenue Market Share by Company (2020-2025)
3.3 Global Alpha Synuclein Sale Price by Company
3.4 Key Manufacturers Alpha Synuclein Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Alpha Synuclein Product Location Distribution
  3.4.2 Players Alpha Synuclein Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ALPHA SYNUCLEIN BY GEOGRAPHIC REGION

4.1 World Historic Alpha Synuclein Market Size by Geographic Region (2020-2025)
  4.1.1 Global Alpha Synuclein Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Alpha Synuclein Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Alpha Synuclein Market Size by Country/Region (2020-2025)
  4.2.1 Global Alpha Synuclein Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Alpha Synuclein Annual Revenue by Country/Region (2020-2025)
4.3 Americas Alpha Synuclein Sales Growth
4.4 APAC Alpha Synuclein Sales Growth
4.5 Europe Alpha Synuclein Sales Growth
4.6 Middle East & Africa Alpha Synuclein Sales Growth

5 AMERICAS

5.1 Americas Alpha Synuclein Sales by Country
  5.1.1 Americas Alpha Synuclein Sales by Country (2020-2025)
  5.1.2 Americas Alpha Synuclein Revenue by Country (2020-2025)
5.2 Americas Alpha Synuclein Sales by Type (2020-2025)
5.3 Americas Alpha Synuclein Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Alpha Synuclein Sales by Region
  6.1.1 APAC Alpha Synuclein Sales by Region (2020-2025)
  6.1.2 APAC Alpha Synuclein Revenue by Region (2020-2025)
6.2 APAC Alpha Synuclein Sales by Type (2020-2025)
6.3 APAC Alpha Synuclein Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Alpha Synuclein by Country
  7.1.1 Europe Alpha Synuclein Sales by Country (2020-2025)
  7.1.2 Europe Alpha Synuclein Revenue by Country (2020-2025)
7.2 Europe Alpha Synuclein Sales by Type (2020-2025)
7.3 Europe Alpha Synuclein Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Alpha Synuclein by Country
  8.1.1 Middle East & Africa Alpha Synuclein Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Alpha Synuclein Revenue by Country (2020-2025)
8.2 Middle East & Africa Alpha Synuclein Sales by Type (2020-2025)
8.3 Middle East & Africa Alpha Synuclein Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alpha Synuclein
10.3 Manufacturing Process Analysis of Alpha Synuclein
10.4 Industry Chain Structure of Alpha Synuclein

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Alpha Synuclein Distributors
11.3 Alpha Synuclein Customer

12 WORLD FORECAST REVIEW FOR ALPHA SYNUCLEIN BY GEOGRAPHIC REGION

12.1 Global Alpha Synuclein Market Size Forecast by Region
  12.1.1 Global Alpha Synuclein Forecast by Region (2026-2031)
  12.1.2 Global Alpha Synuclein Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Alpha Synuclein Forecast by Type (2026-2031)
12.7 Global Alpha Synuclein Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AC Immune SA
  13.1.1 AC Immune SA Company Information
  13.1.2 AC Immune SA Alpha Synuclein Product Portfolios and Specifications
  13.1.3 AC Immune SA Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AC Immune SA Main Business Overview
  13.1.5 AC Immune SA Latest Developments
13.2 AFFiRiS AG
  13.2.1 AFFiRiS AG Company Information
  13.2.2 AFFiRiS AG Alpha Synuclein Product Portfolios and Specifications
  13.2.3 AFFiRiS AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AFFiRiS AG Main Business Overview
  13.2.5 AFFiRiS AG Latest Developments
13.3 BioArctic AB
  13.3.1 BioArctic AB Company Information
  13.3.2 BioArctic AB Alpha Synuclein Product Portfolios and Specifications
  13.3.3 BioArctic AB Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 BioArctic AB Main Business Overview
  13.3.5 BioArctic AB Latest Developments
13.4 Biogen Inc
  13.4.1 Biogen Inc Company Information
  13.4.2 Biogen Inc Alpha Synuclein Product Portfolios and Specifications
  13.4.3 Biogen Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Biogen Inc Main Business Overview
  13.4.5 Biogen Inc Latest Developments
13.5 Evotec AG
  13.5.1 Evotec AG Company Information
  13.5.2 Evotec AG Alpha Synuclein Product Portfolios and Specifications
  13.5.3 Evotec AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Evotec AG Main Business Overview
  13.5.5 Evotec AG Latest Developments
13.6 Genmab A/S
  13.6.1 Genmab A/S Company Information
  13.6.2 Genmab A/S Alpha Synuclein Product Portfolios and Specifications
  13.6.3 Genmab A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Genmab A/S Main Business Overview
  13.6.5 Genmab A/S Latest Developments
13.7 H. Lundbeck A/S
  13.7.1 H. Lundbeck A/S Company Information
  13.7.2 H. Lundbeck A/S Alpha Synuclein Product Portfolios and Specifications
  13.7.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 H. Lundbeck A/S Main Business Overview
  13.7.5 H. Lundbeck A/S Latest Developments
13.8 ICB International Inc
  13.8.1 ICB International Inc Company Information
  13.8.2 ICB International Inc Alpha Synuclein Product Portfolios and Specifications
  13.8.3 ICB International Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 ICB International Inc Main Business Overview
  13.8.5 ICB International Inc Latest Developments
13.9 MedImmune LLC
  13.9.1 MedImmune LLC Company Information
  13.9.2 MedImmune LLC Alpha Synuclein Product Portfolios and Specifications
  13.9.3 MedImmune LLC Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 MedImmune LLC Main Business Overview
  13.9.5 MedImmune LLC Latest Developments
13.10 Neuropore Therapies Inc
  13.10.1 Neuropore Therapies Inc Company Information
  13.10.2 Neuropore Therapies Inc Alpha Synuclein Product Portfolios and Specifications
  13.10.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Neuropore Therapies Inc Main Business Overview
  13.10.5 Neuropore Therapies Inc Latest Developments
13.11 nLife Therapeutics SL
  13.11.1 nLife Therapeutics SL Company Information
  13.11.2 nLife Therapeutics SL Alpha Synuclein Product Portfolios and Specifications
  13.11.3 nLife Therapeutics SL Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 nLife Therapeutics SL Main Business Overview
  13.11.5 nLife Therapeutics SL Latest Developments
13.12 Prothena Corp Plc
  13.12.1 Prothena Corp Plc Company Information
  13.12.2 Prothena Corp Plc Alpha Synuclein Product Portfolios and Specifications
  13.12.3 Prothena Corp Plc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Prothena Corp Plc Main Business Overview
  13.12.5 Prothena Corp Plc Latest Developments
13.13 QR Pharma Inc
  13.13.1 QR Pharma Inc Company Information
  13.13.2 QR Pharma Inc Alpha Synuclein Product Portfolios and Specifications
  13.13.3 QR Pharma Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 QR Pharma Inc Main Business Overview
  13.13.5 QR Pharma Inc Latest Developments
13.14 reMYND NV
  13.14.1 reMYND NV Company Information
  13.14.2 reMYND NV Alpha Synuclein Product Portfolios and Specifications
  13.14.3 reMYND NV Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 reMYND NV Main Business Overview
  13.14.5 reMYND NV Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Alpha Synuclein Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Alpha Synuclein Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of AV-1950R
Table 4. Major Players of AV-1947D
Table 5. Major Players of BAN-0805
Table 6. Major Players of BIIB-054
Table 7. Major Players of DPC-003
Table 8. Major Players of Others
Table 9. Global Alpha Synuclein Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Alpha Synuclein Sales Market Share by Type (2020-2025)
Table 11. Global Alpha Synuclein Revenue by Type (2020-2025) & ($ million)
Table 12. Global Alpha Synuclein Revenue Market Share by Type (2020-2025)
Table 13. Global Alpha Synuclein Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Alpha Synuclein Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Alpha Synuclein Sale Market Share by Application (2020-2025)
Table 16. Global Alpha Synuclein Revenue by Application (2020-2025) & ($ million)
Table 17. Global Alpha Synuclein Revenue Market Share by Application (2020-2025)
Table 18. Global Alpha Synuclein Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Alpha Synuclein Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Alpha Synuclein Sales Market Share by Company (2020-2025)
Table 21. Global Alpha Synuclein Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Alpha Synuclein Revenue Market Share by Company (2020-2025)
Table 23. Global Alpha Synuclein Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Alpha Synuclein Producing Area Distribution and Sales Area
Table 25. Players Alpha Synuclein Products Offered
Table 26. Alpha Synuclein Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Alpha Synuclein Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Alpha Synuclein Sales Market Share Geographic Region (2020-2025)
Table 31. Global Alpha Synuclein Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Alpha Synuclein Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Alpha Synuclein Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Alpha Synuclein Sales Market Share by Country/Region (2020-2025)
Table 35. Global Alpha Synuclein Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Alpha Synuclein Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Alpha Synuclein Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Alpha Synuclein Sales Market Share by Country (2020-2025)
Table 39. Americas Alpha Synuclein Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Alpha Synuclein Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Alpha Synuclein Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Alpha Synuclein Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Alpha Synuclein Sales Market Share by Region (2020-2025)
Table 44. APAC Alpha Synuclein Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Alpha Synuclein Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Alpha Synuclein Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Alpha Synuclein Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Alpha Synuclein Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Alpha Synuclein Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Alpha Synuclein Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Alpha Synuclein Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Alpha Synuclein Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Alpha Synuclein Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Alpha Synuclein Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Alpha Synuclein
Table 56. Key Market Challenges & Risks of Alpha Synuclein
Table 57. Key Industry Trends of Alpha Synuclein
Table 58. Alpha Synuclein Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Alpha Synuclein Distributors List
Table 61. Alpha Synuclein Customer List
Table 62. Global Alpha Synuclein Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Alpha Synuclein Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Alpha Synuclein Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Alpha Synuclein Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Alpha Synuclein Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Alpha Synuclein Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Alpha Synuclein Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Alpha Synuclein Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Alpha Synuclein Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Alpha Synuclein Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Alpha Synuclein Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Alpha Synuclein Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Alpha Synuclein Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Alpha Synuclein Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. AC Immune SA Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 77. AC Immune SA Alpha Synuclein Product Portfolios and Specifications
Table 78. AC Immune SA Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. AC Immune SA Main Business
Table 80. AC Immune SA Latest Developments
Table 81. AFFiRiS AG Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 82. AFFiRiS AG Alpha Synuclein Product Portfolios and Specifications
Table 83. AFFiRiS AG Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. AFFiRiS AG Main Business
Table 85. AFFiRiS AG Latest Developments
Table 86. BioArctic AB Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 87. BioArctic AB Alpha Synuclein Product Portfolios and Specifications
Table 88. BioArctic AB Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. BioArctic AB Main Business
Table 90. BioArctic AB Latest Developments
Table 91. Biogen Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 92. Biogen Inc Alpha Synuclein Product Portfolios and Specifications
Table 93. Biogen Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Biogen Inc Main Business
Table 95. Biogen Inc Latest Developments
Table 96. Evotec AG Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 97. Evotec AG Alpha Synuclein Product Portfolios and Specifications
Table 98. Evotec AG Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Evotec AG Main Business
Table 100. Evotec AG Latest Developments
Table 101. Genmab A/S Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 102. Genmab A/S Alpha Synuclein Product Portfolios and Specifications
Table 103. Genmab A/S Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Genmab A/S Main Business
Table 105. Genmab A/S Latest Developments
Table 106. H. Lundbeck A/S Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 107. H. Lundbeck A/S Alpha Synuclein Product Portfolios and Specifications
Table 108. H. Lundbeck A/S Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. H. Lundbeck A/S Main Business
Table 110. H. Lundbeck A/S Latest Developments
Table 111. ICB International Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 112. ICB International Inc Alpha Synuclein Product Portfolios and Specifications
Table 113. ICB International Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. ICB International Inc Main Business
Table 115. ICB International Inc Latest Developments
Table 116. MedImmune LLC Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 117. MedImmune LLC Alpha Synuclein Product Portfolios and Specifications
Table 118. MedImmune LLC Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. MedImmune LLC Main Business
Table 120. MedImmune LLC Latest Developments
Table 121. Neuropore Therapies Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 122. Neuropore Therapies Inc Alpha Synuclein Product Portfolios and Specifications
Table 123. Neuropore Therapies Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 124. Neuropore Therapies Inc Main Business
Table 125. Neuropore Therapies Inc Latest Developments
Table 126. nLife Therapeutics SL Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 127. nLife Therapeutics SL Alpha Synuclein Product Portfolios and Specifications
Table 128. nLife Therapeutics SL Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 129. nLife Therapeutics SL Main Business
Table 130. nLife Therapeutics SL Latest Developments
Table 131. Prothena Corp Plc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 132. Prothena Corp Plc Alpha Synuclein Product Portfolios and Specifications
Table 133. Prothena Corp Plc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 134. Prothena Corp Plc Main Business
Table 135. Prothena Corp Plc Latest Developments
Table 136. QR Pharma Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 137. QR Pharma Inc Alpha Synuclein Product Portfolios and Specifications
Table 138. QR Pharma Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 139. QR Pharma Inc Main Business
Table 140. QR Pharma Inc Latest Developments
Table 141. reMYND NV Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 142. reMYND NV Alpha Synuclein Product Portfolios and Specifications
Table 143. reMYND NV Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 144. reMYND NV Main Business
Table 145. reMYND NV Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Alpha Synuclein
Figure 2. Alpha Synuclein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alpha Synuclein Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Alpha Synuclein Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Alpha Synuclein Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Alpha Synuclein Sales Market Share by Country/Region (2024)
Figure 10. Alpha Synuclein Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of AV-1950R
Figure 12. Product Picture of AV-1947D
Figure 13. Product Picture of BAN-0805
Figure 14. Product Picture of BIIB-054
Figure 15. Product Picture of DPC-003
Figure 16. Product Picture of Others
Figure 17. Global Alpha Synuclein Sales Market Share by Type in 2025
Figure 18. Global Alpha Synuclein Revenue Market Share by Type (2020-2025)
Figure 19. Alpha Synuclein Consumed in Multiple System Atrophy
Figure 20. Global Alpha Synuclein Market: Multiple System Atrophy (2020-2025) & (K Pcs)
Figure 21. Alpha Synuclein Consumed in Neurodegenerateive Disease
Figure 22. Global Alpha Synuclein Market: Neurodegenerateive Disease (2020-2025) & (K Pcs)
Figure 23. Alpha Synuclein Consumed in Lewy Body Dementia
Figure 24. Global Alpha Synuclein Market: Lewy Body Dementia (2020-2025) & (K Pcs)
Figure 25. Alpha Synuclein Consumed in Others
Figure 26. Global Alpha Synuclein Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Alpha Synuclein Sale Market Share by Application (2024)
Figure 28. Global Alpha Synuclein Revenue Market Share by Application in 2025
Figure 29. Alpha Synuclein Sales by Company in 2025 (K Pcs)
Figure 30. Global Alpha Synuclein Sales Market Share by Company in 2025
Figure 31. Alpha Synuclein Revenue by Company in 2025 ($ millions)
Figure 32. Global Alpha Synuclein Revenue Market Share by Company in 2025
Figure 33. Global Alpha Synuclein Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Alpha Synuclein Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Alpha Synuclein Sales 2020-2025 (K Pcs)
Figure 36. Americas Alpha Synuclein Revenue 2020-2025 ($ millions)
Figure 37. APAC Alpha Synuclein Sales 2020-2025 (K Pcs)
Figure 38. APAC Alpha Synuclein Revenue 2020-2025 ($ millions)
Figure 39. Europe Alpha Synuclein Sales 2020-2025 (K Pcs)
Figure 40. Europe Alpha Synuclein Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Alpha Synuclein Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Alpha Synuclein Revenue 2020-2025 ($ millions)
Figure 43. Americas Alpha Synuclein Sales Market Share by Country in 2025
Figure 44. Americas Alpha Synuclein Revenue Market Share by Country (2020-2025)
Figure 45. Americas Alpha Synuclein Sales Market Share by Type (2020-2025)
Figure 46. Americas Alpha Synuclein Sales Market Share by Application (2020-2025)
Figure 47. United States Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Alpha Synuclein Sales Market Share by Region in 2025
Figure 52. APAC Alpha Synuclein Revenue Market Share by Region (2020-2025)
Figure 53. APAC Alpha Synuclein Sales Market Share by Type (2020-2025)
Figure 54. APAC Alpha Synuclein Sales Market Share by Application (2020-2025)
Figure 55. China Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 59. India Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Alpha Synuclein Sales Market Share by Country in 2025
Figure 63. Europe Alpha Synuclein Revenue Market Share by Country (2020-2025)
Figure 64. Europe Alpha Synuclein Sales Market Share by Type (2020-2025)
Figure 65. Europe Alpha Synuclein Sales Market Share by Application (2020-2025)
Figure 66. Germany Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 67. France Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Alpha Synuclein Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Alpha Synuclein Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Alpha Synuclein Sales Market Share by Application (2020-2025)
Figure 74. Egypt Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Alpha Synuclein Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Alpha Synuclein in 2025
Figure 80. Manufacturing Process Analysis of Alpha Synuclein
Figure 81. Industry Chain Structure of Alpha Synuclein
Figure 82. Channels of Distribution
Figure 83. Global Alpha Synuclein Sales Market Forecast by Region (2026-2031)
Figure 84. Global Alpha Synuclein Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Alpha Synuclein Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Alpha Synuclein Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Alpha Synuclein Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Alpha Synuclein Revenue Market Share Forecast by Application (2026-2031)